{
  "main_header": {
    "sid": 1129474,
    "name": "BML, Inc.",
    "stock_name": "BML, Inc.",
    "full_name": "BML, Inc.",
    "name_url": "stocks-analysis/bml-inc",
    "exchange": 121,
    "exchangecode": "TKS",
    "country_id": 23,
    "currency": "JPY",
    "cmp": "3,820.00",
    "chg": -35,
    "chgp": "-0.91%",
    "dir": -1,
    "prev_price": "3,855.00",
    "mcapval": "156,066.43",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "Japan Nikkei 225",
    "isin": "JP3799700004",
    "curr_date": "Dec 11",
    "curr_time": "",
    "bse_nse_vol": "124.6 k",
    "exc_status": "Active",
    "traded_date": "Dec 11, 2025",
    "traded_date_str": "2025 12 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bml-inc-1129474-121&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "BML, Inc. Adjusts Valuation Amidst Financial Landscape Challenges and Performance Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bml-inc-stock-downgraded-from-buy-to-hold-amid-valuation-decline-3690100",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/BMLInc_mojoScore_3690100.png",
        "date": "2025-11-11 16:54:20",
        "description": "BML, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. This change highlights the company's valuation metrics, including its P/E ratio, Price to Book Value, and operational efficiency indicators, reflecting its financial health and market position amidst recent performance challenges."
      },
      {
        "title": "BML, Inc. Shows Strong Financial Metrics Amid Evolving Market Position",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bml-inc-upgraded-to-buy-by-marketsmojo-amid-improved-valuation-metrics-3559237",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/BMLInc_mojoScore_3559237.png",
        "date": "2025-09-23 16:00:58",
        "description": "BML, Inc., a small-cap pharmaceutical company, has recently adjusted its evaluation, reflecting its competitive market position. With strong financial metrics, including a notable P/E ratio and low debt levels, the company has outperformed the broader market over the past year, showcasing solid operational efficiency and management effectiveness."
      }
    ],
    "total": 2,
    "sid": "1129474",
    "stock_news_url": "https://www.marketsmojo.com/news/bml-inc-1129474"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

BML, Inc. Adjusts Valuation Amidst Financial Landscape Challenges and Performance Metrics

2025-11-11 16:54:20

BML, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has experienced a recent evaluation adjustment. This change highlights the company's valuation metrics, including its P/E ratio, Price to Book Value, and operational efficiency indicators, reflecting its financial health and market position amidst recent performance challenges.

Read More

BML, Inc. Shows Strong Financial Metrics Amid Evolving Market Position

2025-09-23 16:00:58

BML, Inc., a small-cap pharmaceutical company, has recently adjusted its evaluation, reflecting its competitive market position. With strong financial metrics, including a notable P/E ratio and low debt levels, the company has outperformed the broader market over the past year, showcasing solid operational efficiency and management effectiveness.

Read More

View All News